FDA Drug Recalls

Recalls / Class I

Class ID-1827-2015

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

PHENYLephrine HCl, 60 mg added to 250 mL 0.9% Sodium Chloride Injection USP (240 mcg per mL), packaged in 250 ml bags, Rx only, PharMEDium Services, LLC, 12620 W. Airport Blvd., Sugar Land, TX 77478, NDC# 61553-236-50

Affected lot / code info
Lot #: 14317035S, Exp 02/11/15

Why it was recalled

Presence of Particulate Matter: The firm manufactured products using Hospira 0.9% Sodium Chloride, USP injection which were subsequently recalled due to the presence of particulate matter (human hair).

Recalling firm

Firm
Pharmedium Services, LLC
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
150 N Field Dr Ste 350, N/A, Lake Forest, Illinois 60045-2506

Distribution

Quantity
48 bags
Distribution pattern
Nationwide

Timeline

Recall initiated
2015-01-28
FDA classified
2015-09-23
Posted by FDA
2015-09-30
Terminated
2017-01-27
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1827-2015. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: drug · FDA Drug Recalls